Marriage Counselors in Los Gates, CA Accepting Medicare
1 Marriage Counselors found. Showing 1 - 1
 Dr. Olivia Dennis Heathcote, MFT Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 45 Ellenwood Ave, Los Gates, CA 95030 Phone: 408-920-2990 Fax: 408-354-1504 |
News Archive
Clock is ticking for insurance exchange implementation
The idea of a health insurance exchange as laid out in President Barack Obama's signature law seems straightforward: an online marketplace where people will shop for private health insurance, like buying an airline ticket or a hotel room.
Nationwide Children's Hospital offers Meta-iodobenzylguanidine therapy for neuroblastoma
Meta-iodobenzylguanidine (MIBG) therapy is now offered by Hematology/Oncology/Blood and Marrow Transplant at Nationwide Children's Hospital. Patients with neuroblastoma who qualify for treatment with MIBG therapy can be treated in this new facility, with round-the-clock supervision by specially trained staff through video and audio monitoring.
Antiseizure drug use during pregnancy linked with double the risk of having children with autism
Women with epilepsy who take the antiseizure drug valproic acid while pregnant are at more than double the risk of having children with autism spectrum disorder and nearly double the risk of having children with attention deficit hyperactivity disorder (ADHD), according to a study in the October 28, 2020, online issue of Neurology, the medical journal of the American Academy of Neurology.
Specific gene impairment may also protect people with Down syndrome
Scientists from Stanley Manne Children's Research Institute at Ann & Robert H. Lurie Children's Hospital of Chicago discovered that a set of genes with decreased expression in individuals with Down syndrome may lead to clinical abnormalities in this population, such as poor muscle development and heart valve problems.
Oncolytics' REOLYSIN granted FDA Orphan Drug Designation for treatment of gastric cancers
Oncolytics Biotech Inc., a clinical-stage biotechnology company focused on the development of oncolytic viruses as potential cancer therapeutics, today announced that the U.S. Food and Drug Administration has granted an Orphan Drug Designation (ODD) for its lead product candidate, REOLYSIN, for the treatment of gastric cancers.
› Verified 8 days ago